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Microbes continue to evolve by developing elaborate mechanisms to 
circumvent the efficacy or action of the currently available antimicrobial agents 
leading to antimicrobial resistance (AMR).
➢ New policies and renewed research are therefore urgently required to 
mitigate the unfolding crisis of AMR. 
Introduction 
➢This study aimed to evaluate the antimicrobial activity of three crude venoms 
from Bitis arietans (Puff adder), Naja haje (Egyptian cobra), and Naja pallida 
(Red spitting cobra) against gram positive and gram negative bacteria.
Methodology
➢The emergence of antibiotic resistant 
microorganisms drives a critical race against 
time to reveal new molecular structures 
targeting bacteria with new mechanisms of 
action to address this alarming global one 
health crisis. 
➢It  has become increasingly clear that new 
antimicrobial peptides from natural sources 
have attracted the attention in recent years. 
➢The importance of bactericidal action exhibited 
by snake toxins is not only for a better 
understanding of the  snakebite envenomation 
mechanism, but also due to their 
biotechnological potential as model for 
therapeutic agents to combat super bugs.
➢ This findings demonstrated that venoms had 
antibacterial activities as comparable to 
antibiotics  and further investigations are 
essential to screen for specific molecules  
responsible for antibacterial properties.
Discussion
➢Naja haje and Naja pallida venoms exhibit broad 
spectrum of activity against both gram positive 
and gram negative bacteria but Bitis arietans
venom is ineffective against bacterial pathogens. 
➢There is a need to explore which of the 
components of N. haje and N. pallida venom is 
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➢ Snake venoms from Bioken Farm Watamu were freeze-dried and rereconstituted for use in 
the carry out.
➢ Antimicrobial susceptibility test was performed using the disc diffusion method with 
Bacillus cereus and Staphylococcus aureus as gram positive bacteria and Escherichia coli, 
Klebsiella pneumoniae, and Salmonella typhi as gram negative bacteria. 
➢ Eight antimicrobials were selected for comparison including Aztreonam (30 µg), 
Cefpodoxime (10 µg), Cefoxitin (30 µg), Streptomycin (25 µg), Ceftriaxone (30 µg), 
Nalidixic acid (30 µg), Tetracycline (30 µg), and Sulfamethoxazole (25 µg).
➢ B. arietans venom was ineffective against all the tested pathogens.
➢ However, B. cereus and S. aureus were more susceptible to N. haje and N. pallida crude 
venoms than Aztreonam, Cefpodoxime and Nalidixic acid.
➢ S. typhi was more susceptible to N. haje and  N. pallida venoms than Nalidixic acid and 
Sulfamethoxazole.
➢ K. pneumoniae was more susceptible to N. haje and N. pallida crude venoms than 
























One Health Relevance 
The rise of antimicrobial resistance is a global crisis, recognized as one of the greatest 
threats to health today.
Diminishing antimicrobial effectiveness represents a formidable threat to human and 
animal health and the environment and therefore to overall global development.
